STAT

AUGUST 22, 2023

Medical illustration is both an art and a science. But it can have a huge cultural impact, too, as medical student and illustrator Chidiebere Ibe discovered when his illustration of a pregnant Black woman and her fetus went viral in 2021. The image was groundbreaking precisely because it shouldn’t have been. People have a wide range of skin colors, and everyone develops medical conditions; it’s common sense that medical illustrations should feature a diverse range of bodies.

237

237

PharmaVoice

AUGUST 22, 2023

How a pediatric neurologist is advocating for herself and the disabled community in a legal battle with the Howard Hughes Medical Institute.

246

246

STAT

AUGUST 22, 2023

“How has the clinical work you do affected you personally?” We’d come to the Q&A part of the evening in an historic church in eastern Pennsylvania. I had traveled there at the request of a local hospice to talk about my perspective as a doctor with a long career of caring for seriously ill and dying patients. I smiled at the casually dressed older man who asked the question.

236

236

BioPharma Dive

AUGUST 22, 2023

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

Immunity 98

Immunity Immunization Drug Development 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

AUGUST 22, 2023

In the United States, more than 1.6 million people identify as transgender. Of these, more than one-fifth are over the age of 65 , the vast majority of whom transitioned in the latter part of their lives. Transgender Americans are both living and dying among us: precisely why we health care providers must improve our approaches to ensuring dignified and respectful care for transgender elders, especially at the end of life.

228

228

Pulses

AUGUST 22, 2023

By : Victoria L. Williams, PharmD, BCCCP “Dr. Williams, what do I have to do if I want to pursue a career in academia? ” a curious student asked me after class. As a clinical faculty member with 50% of my appointment dedicated to direct patient care and the other 50% to teaching, research/scholarship, and service, my answer started off strong with tried-and-true advice on pursuing residency training to prepare for the practice component of my role.

98

98

Quality Matters

AUGUST 22, 2023

Industry examining FDA guidance on nitrosamines Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as this year has marked the fifth anniversary since they were first detected at unacceptable levels in some blood pressure medications and – even more importantly – due to a flurry of new regulatory activity taking place around the globe this summer, including by the U.S.

Compounding 98

Compounding 98

STAT

AUGUST 22, 2023

Benjamin Young didn’t set out to be the first Native Hawaiian psychiatrist. Nor did he go looking to be the first physician on board what would become a landmark epic voyage from Tahiti to Hawaii back in 1976, using only the stars, sun, moon, and cloud and wave patterns as guides. And Young had no clue that, toward the beginning of his career, he would be called on to start up a first-of-its-kind program at the University of Hawaii to diversify the number of Pacific Islanders and other un

218

218

Pharmaceutical Business Review

AUGUST 22, 2023

These therapies include an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody. Talvey recently received the US Food and Drug Administration’s approval for the same indication in adults who received at least four prior lines of therapy. It is a bispecific antibody that targets T-cell CD-3 receptors and G protein-coupled receptor class C group 5 member D (GPRC5D).

97

97

STAT

AUGUST 22, 2023

WASHINGTON — David Ricks, who leads Eli Lilly, made a major early donation to a super PAC in support of former vice president Mike Pence — one of the first big 2024 donations from a major player in the pharmaceutical industry. Ricks in June donated $25,000 to a special political action committee called Committed to America, which was founded to support Pence.

Drug Pricing 212

Drug Pricing 212

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

AUGUST 22, 2023

The pharma’s suit, which claims Medicare’s new power to negotiate certain drug prices is unconstitutional, comes days before the agency will reveal the first 10 medicines to be included under the plan.

Drug Pricing 97

Drug Pricing 97

STAT

AUGUST 22, 2023

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious. The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant

209

209

Express Pharma

AUGUST 22, 2023

Vadodara-based Shiva Pharmachem, a manufacturer of acid and alkyl chlorides, has filed its Draft Red Herring prospectus (DRHP) with capital market regulator SEBI to raise funds through for its initial public offering (IPO). The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group Selling Shareholders.

93

93

STAT

AUGUST 22, 2023

Good morning, one and all. Damian Garde here, filling in for Ed Silverman once more on another day of aberrant weather and out-of-office autoreplies. Here’s hoping yours ends with fewer open browser tabs than it began. Below find a few items to get you started, and, as always, let us know if you hear anything interesting out there. The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us.

Vaccines 183

Vaccines Drug Pricing Diabetes Pharmaceutical Companies 183

cureatr

AUGUST 22, 2023

Medication Therapy Management (MTM) has always been an important component of the Medicare Advantage Part D plan structure. Potential changes to Part D would not only significantly increase the number of Medicare beneficiaries eligible for MTM enrollment, but they could also adversely impact Medicare star ratings and member outcomes if MTM programs can’t appropriately scale to meet demand.

Medication Therapy Management (MTM) 92

Medication Therapy Management (MTM) 92

Pharma Times

AUGUST 22, 2023

Around 670 people in England with epidermolysis bullosa will benefit from the treatment - News - PharmaTimes

111

111

BioPharma Dive

AUGUST 22, 2023

The biotech, which aims to develop an alternative to existing medicines and emerging gene-based treatments, will focus further testing on sicker patients.

97

97

PharmExec

AUGUST 22, 2023

Amid Twitter's transformation into "X", social media expert Mikaela Walker weighs in on the rebrand's impact for pharma marketing, assesses ongoing brand safety risks, and highlights established social platforms and those gaining traction.

90

90

Express Pharma

AUGUST 22, 2023

A new report from the Access to Medicine Foundation, an independent non-profit organisation, zeroes in on responsible manufacturing, setting out three clear areas pharma companies can focus on to ensure they limit AMR risk when manufacturing their antibiotics. Since the first AMR Benchmark in 2018, the Foundation has been assessing how some of the world’s leading producers of antibiotics perform on limiting AMR risk from manufacturing.

Generic Medicine 89

Generic Medicine Hospitals 89

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. The investment aims to improve vaccines and shorten the time it takes to produce medicines. Winners of a series of competitions centering on the aforementioned topics will obtain funding for UK medicines manufacturing.

Vaccines 88

Vaccines Packaging 88

The Pharmacist

AUGUST 22, 2023

NHS England (NHSE) has launched its independent prescribing pathfinder programme to explore how independent prescribing could be used in community pharmacy. The programme could include up to 210 community pharmacies across each of the 42 Integrated Care Boards (ICBs) in England. Each ICB will be able to determine the scope of their sites, which will […] The post Pilot sites in every ICB to test how pharmacist prescribing could be used appeared first on The Pharmacist.

Community Pharmacies 88

Community Pharmacies 88

Express Pharma

AUGUST 22, 2023

Marksans Pharma has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC). The Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC) are bioequivalent to the reference listed drug (RLD), Mucinex Extended-Release Tablets, 600 mg and 1200 mg, of RB Health (US) LLC.

87

87

World Pharma News

AUGUST 22, 2023

Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.

85

85

European Pharmaceutical Review

AUGUST 22, 2023

Abrysvo is approved for pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants. The US Food and Drug Administration (FDA)-approved treatment, is the first RSV vaccine indicated for infants from birth to six months of age. It is approved for use at 32 through to 36 weeks pregnancy gestation.

Vaccines 83

Vaccines 83

Express Pharma

AUGUST 22, 2023

Despite the continued inflationary pressures, the second quarter (Q2) of 2023 yielded promising outcomes for the leading 20 biopharma giants. The aggregate market capitalisation demonstrated a resilient upswing of 2.3 per cent, surging from $3.49 trillion during the first quarter (Q1) of 2023 to an impressive $3.56 trillion in Q2 2023, reveals GlobalData.

Biosimilars 82

Biosimilars Diabetes 82

Pharma Times

AUGUST 22, 2023

This is the first time that this type of scientific method has been used to detect polio - News - PharmaTimes

99

99

assurecare

AUGUST 22, 2023

In my previous blog, I expressed my profound passion for medication adherence and my dedication to helping people improve their lives. Proper medication adherence is essential, as it can significantly enhance the well-being of numerous individuals. As a refresher, let's define adherence again based on the U.S. Food and Drug Administration (FDA) definition: "Medication adherence, or taking medications correctly, refers to the extent to which patients follow their doctors' prescribed medication re

79

79

Outsourcing Pharma

AUGUST 22, 2023

Actimed Therapeutics Ltd will put some of its additional funding of Â4.75 million ($6 million) towards its attempt to provide the worldâs first cure for cancer cachexia.

98

98

Eye on FDA

AUGUST 22, 2023

For the second time this month and the third time this year, FDA’s OPDP has posted notice that it has taken an enforcement action. Last week, a Warning Letter was posted regarding a sales aid. This week it action came in the form of an Untitled Letter (NOV) sent to a company regarding a paid social media posting. Enforcement this year was non-existent until June when the agency posted its first letter in a year.

Communication 68

Communication Packaging Labelling 68

Drug Channels

AUGUST 22, 2023

Last week, Anna Matthews of The Wall Street Journal scored a market-moving scoop with her story about Blue Cross of California’s decision to ditch CVS Health’s Caremark pharmacy benefit manager (PBM) in favor of five separate vendors. ICYMI: A Big Health Insurer Is Ripping Up the Playbook on Drug Pricing I commend Blue Shield of California for undertaking a noble experiment to unbundle the PBM business model.

Drug Pricing 94

Drug Pricing 94

Outsourcing Pharma

AUGUST 22, 2023

Hutchmed is planning to submit a New Drug Application (NDA) for treatment of primary immune thrombocytopenia (ITP) in China.

Immunity 98

Immunity Immunization 98

PharmaTech

AUGUST 22, 2023

This case study shares why a leading biotech company reached out to Aizon to identify how artificial intelligence (AI) could be used to further optimize yield. The team was able to analyze five years of historical batch data to discover a direct correlation between hold up volume and time between process operations as well as generating millions of additional recovered revenue.

52

52

Outsourcing Pharma

AUGUST 22, 2023

Those in the life sciences industry needing some creative input can now turn to Bios Health Group who have recently launched into the space.

97

97

Welltopia Pharmacy

AUGUST 22, 2023

Looking for a reliable bone health supplement? Explore the benefits of Metagenics Bone Builder and its potential impact on your overall well-being. Get the facts before you make a decision.

52

52

Outsourcing Pharma

AUGUST 22, 2023

QuantHealth announced it has raised a $15 million series A funding round today (August 22) for its clinical simulator that can predict how a patient will respond to treatment in a clinical trial.

52

52